INTEGRATED BIOPHARMA INC Quarterly Income Tax Expense (Benefit) in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Integrated Biopharma Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q3 2024.
  • Integrated Biopharma Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $245K, a 1785% increase year-over-year.
  • Integrated Biopharma Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $388K, a 304% increase year-over-year.
  • Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2024 was $156K, a 16.4% increase from 2023.
  • Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2023 was $134K.
  • Integrated Biopharma Inc annual Income Tax Expense (Benefit) for 2022 was -$1.24M, a 62% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $388K $245K +$232K +1785% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $156K $146K +$103K +240% Apr 1, 2024 Jun 30, 2024 10-K 2024-09-20
Q1 2024 $53K $67K +$37K +123% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $16K -$70K -$80K -800% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $96K $13K -$38K -74.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $134K $43K +$1.13M Apr 1, 2023 Jun 30, 2023 10-K 2024-09-20
Q1 2023 -$996K $30K -$133K -81.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$863K $10K +$350K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 -$1.21M $51K +$28K +122% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.24M -$1.09M +$666K +38% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 -$1.91M $163K -$302K -64.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$1.61M -$340K -$435K -458% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$1.17M $23K -$404K -94.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$766K -$1.75M -$517K -41.8% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 -$249K $465K +$398K +594% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$647K $95K -$17K -15.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$630K $427K +$390K +1054% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$1.02M -$1.24M -$1.33M -1361% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 $314K $67K -$76K -53.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $390K $112K +$54K +93.1% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 $336K $37K -$18K -32.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $354K $98K +$169K Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 $185K $143K +$40K +38.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $145K $58K -$280K -82.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $425K $55K +$99K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $326K -$71K Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 $103K +$35K +51.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $338K +$267K +376% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$44K -$170K -135% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 $68K +$14K +25.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $71K +$51K +255% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $126K +$98K +350% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 $116K $54K +$30K +125% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $86K $20K -$47K -70.1% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $133K $28K -$1K -3.45% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $134K $14K +$56K Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 $78K $24K -$3K -11.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $81K $67K +$6K +9.84% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $75K $29K -$14K -32.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $89K -$42K Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 $27K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $61K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $43K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.